TAM
Taurus Asset Management Portfolio holdings
AUM
$986M
This Quarter Return
-4.08%
1 Year Return
+5.04%
3 Year Return
+26.94%
5 Year Return
+134.98%
10 Year Return
+234.76%
AUM
$747M
AUM Growth
+$747M
(-7.8%)
Cap. Flow
+$772K
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
44.91%
Holding
87
New
–
Increased
9
Reduced
47
Closed
–
Top Buys
| 1 |
Envista
NVST
|
$5.92M |
| 2 |
JPMorgan Chase
JPM
|
$1.92M |
| 3 |
Microsoft
MSFT
|
$1.43M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$189K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$85.3K |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$4.03M |
| 2 |
Apple
AAPL
|
$2.46M |
| 3 |
ServiceNow
NOW
|
$2.27M |
| 4 |
Thermo Fisher Scientific
TMO
|
$2.21M |
| 5 |
Danaher
DHR
|
$2.03M |
Sector Composition
| 1 | Technology | 26.67% |
| 2 | Healthcare | 18.66% |
| 3 | Financials | 12.04% |
| 4 | Consumer Discretionary | 12% |
| 5 | Consumer Staples | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cooper Companies
COO
$13.3B
| $12.6M | 1.68% |
190,820
-10,700
| -5% | -$706K |
|
27
Amphenol
APH
$135B
| $12.2M | 1.63% |
363,626
-11,000
| -3% | -$368K |
|
28
Mondelez International
MDLZ
$79.3B
| $12.1M | 1.61% |
220,053
-10,200
| -4% | -$559K |
|
|
29
SPDR S&P 500 ETF Trust
SPY
$656B
| $11.1M | 1.49% |
31,135
+529
| +2% | +$189K |
|
30
Accenture
ACN
$158B
| $9.33M | 1.25% |
36,255
-805
| -2% | -$207K |
|
|
PXD
31
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.17M | 1.23% |
42,352
-150
| -0.4% | -$32.5K |
|
|
32
Envista
NVST
$3.37B
| $8.14M | 1.09% |
248,060
+180,410
| +267% | +$5.92M |
|
33
Union Pacific
UNP
$132B
| $8.12M | 1.09% |
41,660
-2,600
| -6% | -$507K |
|
34
Ashland
ASH
$2.48B
| $7.93M | 1.06% |
83,468
-14,175
| -15% | -$1.35M |
|
35
Rockwell Automation
ROK
$38.1B
| $7.78M | 1.04% |
36,175
-1,395
| -4% | -$300K |
|
36
Old Dominion Freight Line
ODFL
$31.1B
| $7.69M | 1.03% |
61,788
-2,490
| -4% | -$310K |
|
37
PepsiCo
PEP
$203B
| $7.61M | 1.02% |
46,603
-2,013
| -4% | -$329K |
|
38
EOG Resources
EOG
$65.8B
| $6.81M | 0.91% |
60,960
-1,885
| -3% | -$211K |
|
39
Johnson & Johnson
JNJ
$429B
| $6.59M | 0.88% |
40,343
-905
| -2% | -$148K |
|
40
Advanced Micro Devices
AMD
$263B
| $6.4M | 0.86% |
101,080
+155
| +0.2% | +$9.82K |
|
41
Exxon Mobil
XOM
$477B
| $2.72M | 0.36% |
31,125
-50
| -0.2% | -$4.37K |
|
42
Pfizer
PFE
$141B
| $2.51M | 0.34% |
57,270
-6,806
| -11% | -$298K |
|
43
Starbucks
SBUX
$99.2B
| $2.32M | 0.31% |
27,545
+400
| +1% | +$33.7K |
|
44
Chevron
CVX
$318B
| $1.89M | 0.25% |
13,182
-1,435
| -10% | -$206K |
|
45
Procter & Gamble
PG
$370B
| $1.82M | 0.24% |
14,435
-1,134
| -7% | -$143K |
|
46
Abbott
ABT
$230B
| $1.55M | 0.21% |
15,987
-1,325
| -8% | -$128K |
|
47
AbbVie
ABBV
$374B
| $1.22M | 0.16% |
9,089
| – | – |
|
48
Colgate-Palmolive
CL
$67.7B
| $902K | 0.12% |
12,843
| – | – |
|
49
Eli Lilly
LLY
$661B
| $880K | 0.12% |
2,720
| – | – |
|
50
Berkshire Hathaway Class A
BRK.A
$1.08T
| $813K | 0.11% |
2
| – | – |
|